Authors:
Gefvert, O
Lundberg, T
Wieselgren, IM
Bergstrom, M
Langstrom, B
Wiesel, FA
Lindstrom, L
Citation: O. Gefvert et al., D-2 and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study, EUR NEUROPS, 11(2), 2001, pp. 105-110
Authors:
Flyckt, L
Venizelos, N
Edman, G
Bjerkenstedt, L
Hagenfeldt, L
Wiesel, FA
Citation: L. Flyckt et al., Aberrant tyrosine transport across the cell membrane in patients with schizophrenia, ARCH G PSYC, 58(10), 2001, pp. 953-958
Authors:
Flyckt, L
Wiesel, FA
Borg, J
Edman, G
Ansved, T
Sydow, O
Borg, K
Citation: L. Flyckt et al., Neuromuscular and psychomotor abnormalities in patients with schizophreniaand their first-degree relatives, J PSYCH RES, 34(4-5), 2000, pp. 355-364
Authors:
Flyckt, L
Borg, J
Borg, K
Ansved, T
Edman, G
Bjerkenstedt, L
Wiesel, FA
Citation: L. Flyckt et al., Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia, BIOL PSYCHI, 47(11), 2000, pp. 991-999
Authors:
Yu, JA
Kallstrom, L
Wiesel, FA
Johnson, AE
Citation: Ja. Yu et al., Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol, SYNAPSE, 34(3), 1999, pp. 192-207
Authors:
Flyckt, L
Sydow, O
Bjerkenstedt, L
Edman, G
Rydin, E
Wiesel, FA
Citation: L. Flyckt et al., Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls, PSYCHIAT R, 86(2), 1999, pp. 113-129